Zacks Investment Research
02 Jun 2026, 22:50 UTC · 1h ago
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
Search tags
Zacks Investment Research
02 Jun 2026, 22:50 UTC · 1h ago
Search tags
Story key points
4 claims · impact-rated
Canopy Growth Corporation is projected to report a quarterly EPS of -$0.06 on June 15, 2026, representing a 93.62% improvement over the previous year. — Significant projected growth in earnings per share typically acts as a positive catalyst for a stock's price.
+0.40Canopy Growth's consensus revenue estimate for the upcoming quarter is $53.26 million, an increase of 17.56% year-over-year. — Steady revenue growth indicates expanding business operations and market share.
+0.30The Medical - Products industry, which includes Canopy Growth, is ranked in the bottom 38% of all industries according to Zacks. — Poor industry-wide ranking suggests systemic headwinds that can limit the upside of individual stocks in that sector.
-0.20Continue reading
6 related stories
Canopy Growth currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating suggests a neutral outlook with no immediate strong buy or sell signal.
+0.00Ticker attribution
Model heads
The stock recently declined and is underperforming both the S&P 500 and the Medical sector.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
0 dimensions · 9 clusters
No impact vector found for this article yet.
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Zacks Investment Research
1h ago
